Primrose Bio, Inc.

Industry

  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Antisense, Oligonucleotides
    • Drug Discovery Technologies
      • Genomics-Proteomics
      • Molecular Diversity
  • Services
  • Pharmaceuticals

Other Names/Subsidiaries

  • Primordial Genetics Inc.
See more in Biomedtracker

Latest on Primrose Bio, Inc.

Scrip

Asia Deal Watch: Regenxbio Licenses Two MPS Gene Therapies To Nippon Shinyaku

 
• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regenxbio Calls On Nippon Shinyaku To

Scrip

Finance Watch: ReCode’s Series B Mega-Round Grows Again With $50m Boost

 
• By Mandy Jackson

ReCode Therapeutics , on track with its plan to take its two lead programs into the clinic this year, announced on 19 September that it raised another $50m in series B venture capital, bringing the ro